Loading
Life sciences · Journal article
Journal of Clinical and Diagnostic Research · September 8, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a single uncontrolled case report describing a 57-year-old obese male with dyslipidaemia, hypertension, and type 2 diabetes managed with a 16-day Ayurvedic protocol combining Lekhana Basti with Triphala and concurrent Shamana therapies. The patient showed improvement in lipid parameters and symptoms with no reported adverse events, but without a control group, baseline lipid values, or post-intervention values, the evidence cannot support inference of efficacy beyond hypothesis-generating observation.
Single case report. Single 57-year-old obese male with dyslipidaemia, hypertension, and type 2 diabetes mellitus presenting with progressive weight gain, breathlessness, excessive sweating, heaviness, lethargy, and disturbed sleep.. Intervention: 16-day Ayurvedic treatment protocol comprising Sarvanga Abhyanga, Swedana, Udvartana, Lekhana Niruha Basti with Triphala Gana as Prakshepa, Anuvasana Basti, and concurrent Shamana Chikitsa. n = 1.
57-year-old obese male with dyslipidaemia, hypertension, and type 2 diabetes mellitus treated with 16-day Ayurvedic protocol Improvement was observed in lipid profile parameters, body weight, and subjective symptoms No adverse events were reported during the treatment period
No adverse events were reported during the treatment period
This case cannot guide clinical practice; it is descriptive only. Clinicians should not adopt this Ayurvedic protocol based on a single anecdotal report without controlled evidence, and should await the larger systematic studies the authors recommend.
A single-case report of an Ayurvedic intervention with uncontrolled observation and no comparator; the authors themselves call for larger controlled studies to validate the findings.
As stated by the source record.
Quoted from the source exactly as published.
This case cannot guide clinical practice; it is descriptive only. Clinicians should not adopt this Ayurvedic protocol based on a single anecdotal report without controlled evidence, and should await the larger systematic studies the authors recommend.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Dyslipidaemia is a metabolic disorder commonly associated with obesity, diabetes mellitus, hypertension, and increased cardiovascular risk, contributing significantly to global morbidity and mortality. It is characterised by abnormal levels of serum lipids, including elevated total cholesterol, triglycerides, Low-Density Lipoprotein (LDL), and/or reduced High-Density Lipoprotein (HDL). In Ayurveda, it can be correlated with Medo Dhatu Dushti, Mandagni, and Kapha predominance, where impaired digestive and metabolic fire leads to improper transformation and accumulation of Meda Dhatu. The present case report describes a 57-year-old obese male with dyslipidaemia, hypertension, and type 2 diabetes mellitus, who presented with progressive weight gain, breathlessness on exertion, excessive sweating, heaviness of the body, lethargy, and disturbed sleep. Based on Ayurvedic principles, the condition was assessed as Kapha-Meda Dushti with Agnimandya. The patient was managed with a 16-day Ayurvedic treatment protocol comprising Sarvanga Abhyanga, Swedana, Udvartana, Lekhana Niruha Basti with Triphala Gana as Prakshepa, Anuvasana Basti, and concurrent Shamana Chikitsa aimed at improving Agni, reducing Kapha and Meda, and promoting metabolic correction. Improvement was observed in lipid profile parameters, body weight, and subjective symptoms. No adverse events were reported during the treatment period. The present case suggests a potential supportive role of an integrated Ayurvedic approach combining Shodhana and Shamana therapies in the short-term management of dyslipidaemia, warranting further systematic clinical evaluation through larger controlled clinical studies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.